Abstract:OBJECTIVE:To investigate the metabolism of lipid, calcium and phosphorus in women with endometriosis. METHODS:Clinical data of 223 patients with endometriosis and 200 patients without endometriosis were retrospectively analyzed. Electrochemiluminoimmunoassay was used to detect the levels of serum luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone (T), estradiol (E2) and progesterone (P), and photoelectric colorimetry was used to determine the concentrations of serum triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL), high density lipoprotein (HDL), calcium and phosphorus in the patients with and without endometriosis. RESULTS:The levels of serum P were 2.0 nmol/L and 1.8 nmol/L in endometriosis patients with age < or = 35 years old (case group A) and > 35 years old (case group B), and 1.6 nmol/L and 1.2 nmol/L in patients without endometriosis at age < or = 35 years old (control group A) and > 35 years old (control group B), respectively. A significant difference was found between case group A and control group A, and between case group B and control group B. The levels of serum LH was significantly higher in case group B (7.2 U/L) than that in control group B (6.1 U/L), however, there was no significant difference between case group A (7.0 U/L) and control group A (6.5 U/L). Also no significant difference in serum FSH, T and E2 levels was found between case group A (respectively, 6.2 U/L, 1.1 nmol/L and 269 pmol/L) and control group A (respectively, 6.3 U/L, 1.1 nmol/L and 264 pmol/L), also between case group B (respectively, 6.6 U/L, 1.0 nmol/L and 345 pmol/L) and control group B (6.6 IU/L, 0.9 nmol/L and 279 pmol/L). The concentrations of serum TG in case group A and B (0.71 mmol/L and 0.72 mmol/L) were significantly lower than in control group A and B (0.92 mmol/L and 1.08 mmol/L), respectively. The concentrations of serum LDL in case group A and B [(2.2 +/- 0.5) mmol/L and (2.4 +/- 0.6) mmol/L]were also significantly lower than in control group A and B [(2.4 +/- 0.7) mmol/L and (2.62 +/- 0.63) mmol/L], respectively. However, the concentrations of serum HDL in case group A and B [(1.62 +/- 0.31) mmol/L and (1.53 +/- 0.32) mmol/L] were significantly higher than in control group A and B [(1.48 +/- 0.21) mmol/L and (1.37 +/- 0.22) mmol/L] , respectively. In addition, the concentrations of serum TC were not significantly different between case group A and control group A [(4.2 +/- 0.7) mmol/L and (4.29 +/- 0.71) mmol/L], and between case group B and control group B [(4.4 +/- 0.8) mmol/L and (4.5 +/- 0.7) mmol/L]. The levels of serum phosphorus in case group A and B [(1.01 +/- 0.22) mmol/L and (0.89 +/- 0.18 mmol/L] were significantly lower than in control group A and B [1.23 +/- 0.24 mmol/L and (1.10 +/- 0.13) mmol/L], respectively. But the levels of serum calcium had no significant difference between case group A and control group A [(2.33 +/- 0.23) mmol/L and (2.41 +/- 0.12) mmol/L], and between case group B and control group B [(2.40 +/- 0.28) mmol/L and (2.42 +/- 0.20) mmol/L]. CONCLUSION:The abnormal metabolism of lipid and phosphorus, and the higher levels of serum P may playing a role in the pathogenesis of endometriosis.

Evaluation of complement system proteins C3a, C5a and C6 in patients of endometriosis

Role of Interleukin-6 and Its Receptor in Endometriosis.

Expression of Vascular Cell Adhesion Molecule 1 and Intercellular Adhesion Molecule 1 in Endometrium and Serum in Endometriosis

A comprehensive cell profiling reveals new cell subtypes and immune dysfunction in peritoneal fluid of endometriosis

Correlation of Polypeptide N-Acetylgalactosamine Transferases-3 And-6 to Different Stages of Endometriosis

[Associations of Metabolism of Lipid, Calcium and Phosphate in Endometriosis].

Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis

Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis.

Are cytokine levels in serum, endometrial tissue, and peritoneal fluid a promising predictor to diagnosis of endometriosis-adenomyosis?

The significance of immune microenvironment in patients with endometriosis

Serum Levels of Interleukins in Endometriosis Patients: a Systematic Review and Meta-Analysis

The role of some inflammatory markers, cytokins and tumor markers in diagnosis of endometriosis

The role of selected cytokines from the interleukin-1 family in the peritoneal fluid of women with endometriosis

Identification and Validation of the Signatures of Infiltrating Immune Cells in the Eutopic Endometrium Endometria of Women With Endometriosis

The Role of NK and T Cells in Endometriosis

Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis

Do inflammatory factors play a significant role in etiopathogenesis of endometrial cysts? Part 1

Bioinformatic Analysis of m6A Regulator-Mediated RNA Methylation Modification Patterns and Immune Microenvironment Characterization in Endometriosis

Immunologic Mechanism of CXCL10 and Its Receptor Involved in Endometriosis

Differences in C-type lectin receptors and their adaptor molecules in the peritoneal fluid of patients with endometriosis and gynecologic cancers

Proangiogenic properties of complement protein C1q can contribute to endometriosis